- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01827033
Effects of Meditation
September 14, 2015 updated by: Miriam Mintzer, Johns Hopkins University
This research is being done to learn about the effects of doing meditation (sitting quietly and concentrating) on people's ability to pay attention and be relaxed.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
6
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- BPRU, Johns Hopkins Bayview Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- aged 18-55
- currently enrolled in methadone maintenance program
Exclusion Criteria:
- history of: a severe medical or psychiatric condition (except substance abuse; e.g., schizophrenia); brain trauma affecting cognitive functioning
- prior experience with meditation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: meditation training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
computerized attention task
Time Frame: within 1 week after training
|
discrimination score on the continuous performance task
|
within 1 week after training
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
stress questionnaires
Time Frame: within 1 week after training
|
within 1 week after training
|
|
mindfulness questionnaire
Time Frame: within 1 week after training
|
within 1 week after training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Miriam Z Mintzer, PhD, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
June 1, 2013
Study Completion (Actual)
June 1, 2013
Study Registration Dates
First Submitted
March 29, 2013
First Submitted That Met QC Criteria
April 4, 2013
First Posted (Estimate)
April 9, 2013
Study Record Updates
Last Update Posted (Estimate)
September 16, 2015
Last Update Submitted That Met QC Criteria
September 14, 2015
Last Verified
November 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- NA_00082735
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.